492 related articles for article (PubMed ID: 26682981)
1. Th17 Cell Pathway in Human Immunity: Lessons from Genetics and Therapeutic Interventions.
Patel DD; Kuchroo VK
Immunity; 2015 Dec; 43(6):1040-51. PubMed ID: 26682981
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy and other primary immunodeficiency diseases help to resolve the nature of protective immunity against chronic mucocutaneous candidiasis.
Kisand K; Peterson P
Curr Opin Pediatr; 2013 Dec; 25(6):715-21. PubMed ID: 24240291
[TBL] [Abstract][Full Text] [Related]
3. Targeting Th17 cells in autoimmune diseases.
Yang J; Sundrud MS; Skepner J; Yamagata T
Trends Pharmacol Sci; 2014 Oct; 35(10):493-500. PubMed ID: 25131183
[TBL] [Abstract][Full Text] [Related]
4. The IL-17 pathway as a major therapeutic target in autoimmune diseases.
Hu Y; Shen F; Crellin NK; Ouyang W
Ann N Y Acad Sci; 2011 Jan; 1217():60-76. PubMed ID: 21155836
[TBL] [Abstract][Full Text] [Related]
5. Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies.
Maddur MS; Miossec P; Kaveri SV; Bayry J
Am J Pathol; 2012 Jul; 181(1):8-18. PubMed ID: 22640807
[TBL] [Abstract][Full Text] [Related]
6. Role of IL-17 and IL-22 in autoimmunity and cancer.
Blake SJ; Teng MW
Actas Dermosifiliogr; 2014 Oct; 105 Suppl 1():41-50. PubMed ID: 25398491
[TBL] [Abstract][Full Text] [Related]
7. Suppression of human and mouse Th17 differentiation and autoimmunity by an endogenous Interleukin 23 receptor cytokine-binding homology region.
Guo W; Luo C; Wang C; Wang YH; Wang X; Gao XD; Yao WB
Int J Biochem Cell Biol; 2014 Oct; 55():304-10. PubMed ID: 25263529
[TBL] [Abstract][Full Text] [Related]
8. Th17 and non-classic Th1 cells in chronic inflammatory disorders: two sides of the same coin.
Cosmi L; Liotta F; Maggi E; Romagnani S; Annunziato F
Int Arch Allergy Immunol; 2014; 164(3):171-7. PubMed ID: 25033972
[TBL] [Abstract][Full Text] [Related]
9. A novel human STAT3 mutation presents with autoimmunity involving Th17 hyperactivation.
Wienke J; Janssen W; Scholman R; Spits H; van Gijn M; Boes M; van Montfrans J; Moes N; de Roock S
Oncotarget; 2015 Aug; 6(24):20037-42. PubMed ID: 26343524
[TBL] [Abstract][Full Text] [Related]
10. The CD27 and CD70 costimulatory pathway inhibits effector function of T helper 17 cells and attenuates associated autoimmunity.
Coquet JM; Middendorp S; van der Horst G; Kind J; Veraar EA; Xiao Y; Jacobs H; Borst J
Immunity; 2013 Jan; 38(1):53-65. PubMed ID: 23159439
[TBL] [Abstract][Full Text] [Related]
11. Exploring the role of interleukin-22 in neurological and autoimmune disorders.
Xin N; Namaka MP; Dou C; Zhang Y
Int Immunopharmacol; 2015 Oct; 28(2):1076-83. PubMed ID: 26311525
[TBL] [Abstract][Full Text] [Related]
12. miRNAs Alter T Helper 17 Cell Fate in the Pathogenesis of Autoimmune Diseases.
Huang J; Xu X; Yang J
Front Immunol; 2021; 12():593473. PubMed ID: 33968012
[TBL] [Abstract][Full Text] [Related]
13. Th17 cells in renal inflammation and autoimmunity.
Dolff S; Witzke O; Wilde B
Autoimmun Rev; 2019 Feb; 18(2):129-136. PubMed ID: 30572135
[TBL] [Abstract][Full Text] [Related]
14. Targeting Interleukin-23 in the Treatment of Noninfectious Uveitis.
Pepple KL; Lin P
Ophthalmology; 2018 Dec; 125(12):1977-1983. PubMed ID: 30458922
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of interleukin-17, interleukin-23 and the TH17 cell pathway in the treatment of psoriatic arthritis and psoriasis.
Mease PJ
Curr Opin Rheumatol; 2015 Mar; 27(2):127-33. PubMed ID: 25599143
[TBL] [Abstract][Full Text] [Related]
16. Effect of IL-17A blockade with secukinumab in autoimmune diseases.
Patel DD; Lee DM; Kolbinger F; Antoni C
Ann Rheum Dis; 2013 Apr; 72 Suppl 2():ii116-23. PubMed ID: 23253932
[TBL] [Abstract][Full Text] [Related]
17. Invariant NKT cells regulate experimental autoimmune uveitis through inhibition of Th17 differentiation.
Oh K; Byoun OJ; Ham DI; Kim YS; Lee DS
Eur J Immunol; 2011 Feb; 41(2):392-402. PubMed ID: 21268009
[TBL] [Abstract][Full Text] [Related]
18. Th17 cells and IL-17 a--focus on immunopathogenesis and immunotherapeutics.
van den Berg WB; McInnes IB
Semin Arthritis Rheum; 2013 Oct; 43(2):158-70. PubMed ID: 24157091
[TBL] [Abstract][Full Text] [Related]
19. IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential.
Zhu S; Qian Y
Clin Sci (Lond); 2012 Jun; 122(11):487-511. PubMed ID: 22324470
[TBL] [Abstract][Full Text] [Related]
20. The role and modulation of CCR6+ Th17 cell populations in rheumatoid arthritis.
Paulissen SM; van Hamburg JP; Dankers W; Lubberts E
Cytokine; 2015 Jul; 74(1):43-53. PubMed ID: 25828206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
